Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy.

Rocca WA, Grossardt BR, Geda YE, Gostout BS, Bower JH, Maraganore DM, de Andrade M, Melton LJ 3rd.

Menopause. 2018 Nov;25(11):1275-1285. doi: 10.1097/GME.0000000000001229.

PMID:
30358723
2.

Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.

Matsuo K, Machida H, Mariani A, Mandelbaum RS, Glaser GE, Gostout BS, Roman LD, Wright JD.

J Gynecol Oncol. 2018 Sep;29(5):e69. doi: 10.3802/jgo.2018.29.e69. Epub 2018 May 4.

3.

OB Nest: Reimagining Low-Risk Prenatal Care.

de Mooij MJM, Hodny RL, O'Neil DA, Gardner MR, Beaver M, Brown AT, Barry BA, Ross LM, Jasik AJ, Nesbitt KM, Sobolewski SM, Skinner SM, Chaudhry R, Brost BC, Gostout BS, Harms RW.

Mayo Clin Proc. 2018 Apr;93(4):458-466. doi: 10.1016/j.mayocp.2018.01.022. Epub 2018 Mar 12. Review.

PMID:
29545005
4.

Intrapartum factors associated with neonatal hypoxic ischemic encephalopathy: a case-controlled study.

Torbenson VE, Tolcher MC, Nesbitt KM, Colby CE, El-Nashar SA, Gostout BS, Weaver AL, Mc Gree ME, Famuyide AO.

BMC Pregnancy Childbirth. 2017 Dec 11;17(1):415. doi: 10.1186/s12884-017-1610-3.

5.

Clinical Utility of Preoperative Computed Tomography in Patients With Endometrial Cancer.

Bogani G, Gostout BS, Dowdy SC, Multinu F, Casarin J, Cliby WA, Frigerio L, Kim B, Weaver AL, Glaser GE, Mariani A.

Int J Gynecol Cancer. 2017 Oct;27(8):1685-1693. doi: 10.1097/IGC.0000000000001076.

PMID:
28704325
6.

Stress and burnout among gynecologic oncologists: A Society of Gynecologic Oncology Evidence-based Review and Recommendations.

Cass I, Duska LR, Blank SV, Cheng G, duPont NC, Frederick PJ, Hill EK, Matthews CM, Pua TL, Rath KS, Ruskin R, Thaker PH, Berchuck A, Gostout BS, Kushner DM, Fowler JM.

Gynecol Oncol. 2016 Nov;143(2):421-427. doi: 10.1016/j.ygyno.2016.08.319. Epub 2016 Aug 27. Review. No abstract available.

PMID:
27575910
7.

Primary brain metastases of endometrial cancer: A report of 18 cases and review of the literature.

Uccella S, Morris JM, Multinu F, Cliby WA, Podratz KC, Gostout BS, Dowdy SC, Ghezzi F, Makdisi PB, Keeney GL, Link MJ, Mariani A.

Gynecol Oncol. 2016 Jul;142(1):70-75. doi: 10.1016/j.ygyno.2016.04.013. Epub 2016 Apr 26. Review.

PMID:
27095189
8.

Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures.

Winterhoff B, Hamidi H, Wang C, Kalli KR, Fridley BL, Dering J, Chen HW, Cliby WA, Wang HJ, Dowdy S, Gostout BS, Keeney GL, Goode EL, Konecny GE.

Gynecol Oncol. 2016 Apr;141(1):95-100. doi: 10.1016/j.ygyno.2016.02.023.

9.

Incorporating robotic-assisted surgery for endometrial cancer staging: Analysis of morbidity and costs.

Bogani G, Multinu F, Dowdy SC, Cliby WA, Wilson TO, Gostout BS, Weaver AL, Borah BJ, Killian JM, Bijlani A, Angioni S, Mariani A.

Gynecol Oncol. 2016 May;141(2):218-224. doi: 10.1016/j.ygyno.2016.02.016. Epub 2016 Feb 16.

PMID:
26896826
10.

Impact of a labor and delivery safety bundle on a modified adverse outcomes index.

Tolcher MC, Torbenson VE, Weaver AL, McGree ME, El-Nashar SA, Nesbitt KM, Gostout BS, Famuyide AO.

Am J Obstet Gynecol. 2016 Mar;214(3):401.e1-9. doi: 10.1016/j.ajog.2016.01.155. Epub 2016 Jan 21.

PMID:
26802579
11.

Implementation of a new prenatal care model to reduce office visits and increase connectivity and continuity of care: protocol for a mixed-methods study.

Ridgeway JL, LeBlanc A, Branda M, Harms RW, Morris MA, Nesbitt K, Gostout BS, Barkey LM, Sobolewski SM, Brodrick E, Inselman J, Baron A, Sivly A, Baker M, Finnie D, Chaudhry R, Famuyide AO.

BMC Pregnancy Childbirth. 2015 Dec 2;15:323. doi: 10.1186/s12884-015-0762-2.

12.

Incisional Recurrences After Endometrial Cancer Surgery.

Bogani G, Dowdy SC, Cliby WA, Gostout BS, Kumar S, Ghezzi F, Multinu F, Mariani A.

Anticancer Res. 2015 Nov;35(11):6097-104.

PMID:
26504035
13.

Robotic radical hysterectomy in early stage cervical cancer: A systematic review and meta-analysis.

Shazly SA, Murad MH, Dowdy SC, Gostout BS, Famuyide AO.

Gynecol Oncol. 2015 Aug;138(2):457-71. doi: 10.1016/j.ygyno.2015.06.009. Epub 2015 Jun 6. Review.

PMID:
26056752
14.

Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy.

Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Martin JR, Keeney GL, Jatoi A, Gostout BS, Podratz KC.

Gynecol Oncol. 2014 Mar;132(3):578-84. doi: 10.1016/j.ygyno.2014.01.007. Epub 2014 Jan 14.

15.

Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.

Giuntoli RL 2nd, Lessard-Anderson CR, Gerardi MA, Kushnir CL, Cliby WA, Metzinger DS, Gostout BS.

Int J Gynecol Cancer. 2013 Jun;23(5):869-76. doi: 10.1097/IGC.0b013e3182916a1e.

PMID:
23669444
16.

In reply: risk factors for developing endometrial cancer.

Torres ML, Famuyide AO, Cliby WA, Dowdy SC, Gostout BS, Mariani A.

Obstet Gynecol. 2013 Feb;121(2 Pt 1):382. doi: http://10.1097/AOG.0b013e318280a338. No abstract available.

PMID:
23344298
17.

The learning curve of robotic hysterectomy.

Woelk JL, Casiano ER, Weaver AL, Gostout BS, Trabuco EC, Gebhart JB.

Obstet Gynecol. 2013 Jan;121(1):87-95. doi: http://10.1097/AOG.0b013e31827a029e.

PMID:
23262932
18.

Risk factors for developing endometrial cancer after benign endometrial sampling.

Torres ML, Weaver AL, Kumar S, Uccella S, Famuyide AO, Cliby WA, Dowdy SC, Gostout BS, Mariani A.

Obstet Gynecol. 2012 Nov;120(5):998-1004. doi: http://10.1097/AOG.0b013e31826b9fef.

19.

Recognizing and treating ovarian cancer.

Gostout BS, Pachman DR, Lechner R.

Minn Med. 2012 Mar;95(3):40-2.

PMID:
22611819
20.

Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma.

Bakkum-Gamez JN, Langstraat CL, Martin JR, Lemens MA, Weaver AL, Allensworth S, Dowdy SC, Cliby WA, Gostout BS, Podratz KC.

Gynecol Oncol. 2012 Jun;125(3):614-20. doi: 10.1016/j.ygyno.2012.02.027. Epub 2012 Feb 24.

21.

Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.

Pachman DR, Barton DL, Clayton AC, McGovern RM, Jefferies JA, Novotny PJ, Sloan JA, Loprinzi CL, Gostout BS.

Am J Obstet Gynecol. 2012 Jan;206(1):42.e1-7. doi: 10.1016/j.ajog.2011.06.105. Epub 2011 Jul 13.

22.

The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer.

Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Gostout BS, Stanhope CR, Wilson TO, Podratz KC.

Gynecol Oncol. 2011 Oct;123(1):58-64. doi: 10.1016/j.ygyno.2011.06.018. Epub 2011 Jul 13.

PMID:
21741696
23.

Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients.

Gorny KR, Woodrum DA, Brown DL, Henrichsen TL, Weaver AL, Amrami KK, Hangiandreou NJ, Edmonson HA, Bouwsma EV, Stewart EA, Gostout BS, Ehman DA, Hesley GK.

J Vasc Interv Radiol. 2011 Jun;22(6):857-64. doi: 10.1016/j.jvir.2011.01.458. Epub 2011 Apr 8.

24.

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.

Pruthi S, Gostout BS, Lindor NM.

Mayo Clin Proc. 2010 Dec;85(12):1111-20. doi: 10.4065/mcp.2010.0414. Review.

25.

Magnetic resonance elastography of uterine leiomyomas: a feasibility study.

Stewart EA, Taran FA, Chen J, Gostout BS, Woodrum DA, Felmlee JP, Ehman RL.

Fertil Steril. 2011 Jan;95(1):281-4. doi: 10.1016/j.fertnstert.2010.06.004. Epub 2010 Jul 15.

26.

Understanding cellular leiomyomas: a case-control study.

Taran FA, Weaver AL, Gostout BS, Stewart EA.

Am J Obstet Gynecol. 2010 Aug;203(2):109.e1-6. doi: 10.1016/j.ajog.2010.03.018. Epub 2010 May 10.

PMID:
20451890
27.

Premature menopause or early menopause: long-term health consequences.

Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA.

Maturitas. 2010 Feb;65(2):161-6. doi: 10.1016/j.maturitas.2009.08.003. Epub 2009 Sep 5. Review.

28.

Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience.

Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope RC, Wilson TO, Podratz KC, Cliby WA.

J Am Coll Surg. 2009 Apr;208(4):614-20. doi: 10.1016/j.jamcollsurg.2009.01.006.

PMID:
19476798
29.

Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging.

Rocca WA, Shuster LT, Grossardt BR, Maraganore DM, Gostout BS, Geda YE, Melton LJ 3rd.

Womens Health (Lond). 2009 Jan;5(1):39-48. doi: 10.2217/17455057.5.1.39.

30.

Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids.

Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA; MRgFUS Study Group.

Fertil Steril. 2010 Jan;93(1):199-209. doi: 10.1016/j.fertnstert.2008.10.001. Epub 2008 Nov 14.

PMID:
19013566
31.

Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment.

Aletti GD, Podratz KC, Cliby WA, Gostout BS.

Gynecol Oncol. 2009 Jan;112(1):22-7. doi: 10.1016/j.ygyno.2008.09.010. Epub 2008 Oct 23.

PMID:
18947860
32.

Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy.

Rocca WA, Grossardt BR, Geda YE, Gostout BS, Bower JH, Maraganore DM, de Andrade M, Melton LJ 3rd.

Menopause. 2008 Nov-Dec;15(6):1050-9. doi: 10.1097/gme.0b013e318174f155.

PMID:
18724263
33.

Prophylactic oophorectomy in premenopausal women and long-term health.

Shuster LT, Gostout BS, Grossardt BR, Rocca WA.

Menopause Int. 2008 Sep;14(3):111-6. doi: 10.1258/mi.2008.008016. Review.

34.

Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.

Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC.

Gynecol Oncol. 2008 Apr;109(1):11-8. doi: 10.1016/j.ygyno.2008.01.023. Epub 2008 Mar 4.

35.

Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.

Giuntoli RL 2nd, Gostout BS, DiMarco CS, Metzinger DS, Keeney GL.

J Reprod Med. 2007 Nov;52(11):1001-10.

PMID:
18161397
36.

Prevention, diagnosis, and treatment of cervical cancer.

Long HJ 3rd, Laack NN, Gostout BS.

Mayo Clin Proc. 2007 Dec;82(12):1566-74. Review.

PMID:
18053467
37.

Human papillomavirus in vulvar vestibulitis syndrome.

Gaunt G, Good AE, McGovern RM, Stanhope CR, Gostout BS.

J Reprod Med. 2007 Jun;52(6):485-9.

PMID:
17694965
38.

Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma.

Giuntoli RL 2nd, Garrett-Mayer E, Bristow RE, Gostout BS.

Gynecol Oncol. 2007 Jul;106(1):82-8. Epub 2007 Apr 16.

PMID:
17434579
39.

Successful term pregnancy following MR-guided focused ultrasound treatment of uterine leiomyoma.

Gavrilova-Jordan LP, Rose CH, Traynor KD, Brost BC, Gostout BS.

J Perinatol. 2007 Jan;27(1):59-61.

PMID:
17180132
40.

Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists.

Society of Gynecologic Oncologists Education Resource Panel Writing group, Collins Y, Einstein MH, Gostout BS, Herzog TJ, Massad LS, Rader JS, Wright J.

Gynecol Oncol. 2006 Sep;102(3):552-62. Review.

PMID:
16979432
41.

Guidelines for referral of the patient with an adnexal mass.

Gostout BS, Brewer MA.

Clin Obstet Gynecol. 2006 Sep;49(3):448-58. Review.

PMID:
16885652
42.

Noninvasive treatment of uterine fibroids: early Mayo Clinic experience with magnetic resonance imaging-guided focused ultrasound.

Hesley GK, Felmlee JP, Gebhart JB, Dunagan KT, Gorny KR, Kesler JB, Brandt KR, Glantz JN, Gostout BS.

Mayo Clin Proc. 2006 Jul;81(7):936-42. Review.

PMID:
16835973
43.

MR guided focused ultrasound: technical acceptance measures for a clinical system.

Gorny KR, Hangiandreou NJ, Hesley GK, Gostout BS, McGee KP, Felmlee JP.

Phys Med Biol. 2006 Jun 21;51(12):3155-73. Epub 2006 Jun 6.

PMID:
16757869
44.

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.

Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, Podratz KC, Cliby WA.

Obstet Gynecol. 2006 Jan;107(1):77-85.

45.

Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon.

Aletti GD, Gostout BS, Podratz KC, Cliby WA.

Gynecol Oncol. 2006 Jan;100(1):33-7. Epub 2005 Sep 8. Erratum in: Gynecol Oncol. 2006 Jun;101(3):553.

PMID:
16153692
46.

Screening for cervical cancer and initial treatment of patients with abnormal results from papanicolaou testing.

Bundrick JB, Cook DA, Gostout BS.

Mayo Clin Proc. 2005 Aug;80(8):1063-8. Review.

PMID:
16092586
47.

Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines.

Dowdy SC, Gostout BS, Shridhar V, Wu X, Smith DI, Podratz KC, Jiang SW.

Gynecol Oncol. 2005 Oct;99(1):126-34.

PMID:
16023706
48.

Validation of referral guidelines for women with pelvic masses.

Im SS, Gordon AN, Buttin BM, Leath CA 3rd, Gostout BS, Shah C, Hatch KD, Wang J, Berman ML.

Obstet Gynecol. 2005 Jan;105(1):35-41.

PMID:
15625139
49.
50.

Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.

Contag SA, Gostout BS, Clayton AC, Dixon MH, McGovern RM, Calhoun ES.

Gynecol Oncol. 2004 Dec;95(3):610-7.

PMID:
15581972

Supplemental Content

Loading ...
Support Center